Global Oseltamivir Phosphate for Oral Suspension Market Growth 2022-2028
Influenza A and B treatment and prevention for adults and children.Dry suspensions refer to insoluble drugs and suitable excipients made into powders or granules, which can be dispersed into suspensions for oral administration by adding water and shaking before use.
The global market for Oseltamivir Phosphate for Oral Suspension is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Oseltamivir Phosphate for Oral Suspension market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Oseltamivir Phosphate for Oral Suspension market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Oseltamivir Phosphate for Oral Suspension market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Oseltamivir Phosphate for Oral Suspension market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Oseltamivir Phosphate for Oral Suspension players cover HEC, Bright Gene, Brilliant Pharma, Kanon and Hetero Labs, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Oseltamivir Phosphate for Oral Suspension market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Oseltamivir Phosphate for Oral Suspension market, with both quantitative and qualitative data, to help readers understand how the Oseltamivir Phosphate for Oral Suspension market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Oseltamivir Phosphate for Oral Suspension market and forecasts the market size by Specification (Aldult and Child,), by Application (Hospital, Clinic and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by specification
Aldult
Child
Segmentation by application
Hospital
Clinic
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
HEC
Bright Gene
Brilliant Pharma
Kanon
Hetero Labs
Roche
SJZ No.4 Pharma
KFBIO
Qilu Pharmaceutical
Wanhan Pharmaceutical
Nucien
Amneal Pharma
Erye Pharma
Alvogen
Chapter Introduction
Chapter 1: Scope of Oseltamivir Phosphate for Oral Suspension, Research Methodology, etc.
Chapter 2: Executive Summary, global Oseltamivir Phosphate for Oral Suspension market size (sales and revenue) and CAGR, Oseltamivir Phosphate for Oral Suspension market size by region, by specification, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Oseltamivir Phosphate for Oral Suspension sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Oseltamivir Phosphate for Oral Suspension sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by specification, and specification.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Oseltamivir Phosphate for Oral Suspension market size forecast by region, by country, by specification, and application.
Chapter 13: Comprehensive company profiles of the leading players, including HEC, Bright Gene, Brilliant Pharma, Kanon, Hetero Labs, Roche, SJZ No.4 Pharma, KFBIO and Qilu Pharmaceutical, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oseltamivir Phosphate for Oral Suspension Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Oseltamivir Phosphate for Oral Suspension by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Oseltamivir Phosphate for Oral Suspension by Country/Region, 2017, 2022 & 2028
2.2 Oseltamivir Phosphate for Oral Suspension Segment by Specification
2.2.1 Aldult
2.2.2 Child
2.3 Oseltamivir Phosphate for Oral Suspension Sales by Specification
2.3.1 Global Oseltamivir Phosphate for Oral Suspension Sales Market Share by Specification (2017-2022)
2.3.2 Global Oseltamivir Phosphate for Oral Suspension Revenue and Market Share by Specification (2017-2022)
2.3.3 Global Oseltamivir Phosphate for Oral Suspension Sale Price by Specification (2017-2022)
2.4 Oseltamivir Phosphate for Oral Suspension Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Oseltamivir Phosphate for Oral Suspension Sales by Application
2.5.1 Global Oseltamivir Phosphate for Oral Suspension Sale Market Share by Application (2017-2022)
2.5.2 Global Oseltamivir Phosphate for Oral Suspension Revenue and Market Share by Application (2017-2022)
2.5.3 Global Oseltamivir Phosphate for Oral Suspension Sale Price by Application (2017-2022)
3 Global Oseltamivir Phosphate for Oral Suspension by Company
3.1 Global Oseltamivir Phosphate for Oral Suspension Breakdown Data by Company
3.1.1 Global Oseltamivir Phosphate for Oral Suspension Annual Sales by Company (2020-2022)
3.1.2 Global Oseltamivir Phosphate for Oral Suspension Sales Market Share by Company (2020-2022)
3.2 Global Oseltamivir Phosphate for Oral Suspension Annual Revenue by Company (2020-2022)
3.2.1 Global Oseltamivir Phosphate for Oral Suspension Revenue by Company (2020-2022)
3.2.2 Global Oseltamivir Phosphate for Oral Suspension Revenue Market Share by Company (2020-2022)
3.3 Global Oseltamivir Phosphate for Oral Suspension Sale Price by Company
3.4 Key Manufacturers Oseltamivir Phosphate for Oral Suspension Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oseltamivir Phosphate for Oral Suspension Product Location Distribution
3.4.2 Players Oseltamivir Phosphate for Oral Suspension Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Oseltamivir Phosphate for Oral Suspension by Geographic Region
4.1 World Historic Oseltamivir Phosphate for Oral Suspension Market Size by Geographic Region (2017-2022)
4.1.1 Global Oseltamivir Phosphate for Oral Suspension Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Oseltamivir Phosphate for Oral Suspension Annual Revenue by Geographic Region
4.2 World Historic Oseltamivir Phosphate for Oral Suspension Market Size by Country/Region (2017-2022)
4.2.1 Global Oseltamivir Phosphate for Oral Suspension Annual Sales by Country/Region (2017-2022)
4.2.2 Global Oseltamivir Phosphate for Oral Suspension Annual Revenue by Country/Region
4.3 Americas Oseltamivir Phosphate for Oral Suspension Sales Growth
4.4 APAC Oseltamivir Phosphate for Oral Suspension Sales Growth
4.5 Europe Oseltamivir Phosphate for Oral Suspension Sales Growth
4.6 Middle East & Africa Oseltamivir Phosphate for Oral Suspension Sales Growth
5 Americas
5.1 Americas Oseltamivir Phosphate for Oral Suspension Sales by Country
5.1.1 Americas Oseltamivir Phosphate for Oral Suspension Sales by Country (2017-2022)
5.1.2 Americas Oseltamivir Phosphate for Oral Suspension Revenue by Country (2017-2022)
5.2 Americas Oseltamivir Phosphate for Oral Suspension Sales by Specification
5.3 Americas Oseltamivir Phosphate for Oral Suspension Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oseltamivir Phosphate for Oral Suspension Sales by Region
6.1.1 APAC Oseltamivir Phosphate for Oral Suspension Sales by Region (2017-2022)
6.1.2 APAC Oseltamivir Phosphate for Oral Suspension Revenue by Region (2017-2022)
6.2 APAC Oseltamivir Phosphate for Oral Suspension Sales by Specification
6.3 APAC Oseltamivir Phosphate for Oral Suspension Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oseltamivir Phosphate for Oral Suspension by Country
7.1.1 Europe Oseltamivir Phosphate for Oral Suspension Sales by Country (2017-2022)
7.1.2 Europe Oseltamivir Phosphate for Oral Suspension Revenue by Country (2017-2022)
7.2 Europe Oseltamivir Phosphate for Oral Suspension Sales by Specification
7.3 Europe Oseltamivir Phosphate for Oral Suspension Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oseltamivir Phosphate for Oral Suspension by Country
8.1.1 Middle East & Africa Oseltamivir Phosphate for Oral Suspension Sales by Country (2017-2022)
8.1.2 Middle East & Africa Oseltamivir Phosphate for Oral Suspension Revenue by Country (2017-2022)
8.2 Middle East & Africa Oseltamivir Phosphate for Oral Suspension Sales by Specification
8.3 Middle East & Africa Oseltamivir Phosphate for Oral Suspension Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oseltamivir Phosphate for Oral Suspension
10.3 Manufacturing Process Analysis of Oseltamivir Phosphate for Oral Suspension
10.4 Industry Chain Structure of Oseltamivir Phosphate for Oral Suspension
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oseltamivir Phosphate for Oral Suspension Distributors
11.3 Oseltamivir Phosphate for Oral Suspension Customer
12 World Forecast Review for Oseltamivir Phosphate for Oral Suspension by Geographic Region
12.1 Global Oseltamivir Phosphate for Oral Suspension Market Size Forecast by Region
12.1.1 Global Oseltamivir Phosphate for Oral Suspension Forecast by Region (2023-2028)
12.1.2 Global Oseltamivir Phosphate for Oral Suspension Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oseltamivir Phosphate for Oral Suspension Forecast by Specification
12.7 Global Oseltamivir Phosphate for Oral Suspension Forecast by Application
13 Key Players Analysis
13.1 HEC
13.1.1 HEC Company Information
13.1.2 HEC Oseltamivir Phosphate for Oral Suspension Product Offered
13.1.3 HEC Oseltamivir Phosphate for Oral Suspension Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 HEC Main Business Overview
13.1.5 HEC Latest Developments
13.2 Bright Gene
13.2.1 Bright Gene Company Information
13.2.2 Bright Gene Oseltamivir Phosphate for Oral Suspension Product Offered
13.2.3 Bright Gene Oseltamivir Phosphate for Oral Suspension Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bright Gene Main Business Overview
13.2.5 Bright Gene Latest Developments
13.3 Brilliant Pharma
13.3.1 Brilliant Pharma Company Information
13.3.2 Brilliant Pharma Oseltamivir Phosphate for Oral Suspension Product Offered
13.3.3 Brilliant Pharma Oseltamivir Phosphate for Oral Suspension Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Brilliant Pharma Main Business Overview
13.3.5 Brilliant Pharma Latest Developments
13.4 Kanon
13.4.1 Kanon Company Information
13.4.2 Kanon Oseltamivir Phosphate for Oral Suspension Product Offered
13.4.3 Kanon Oseltamivir Phosphate for Oral Suspension Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Kanon Main Business Overview
13.4.5 Kanon Latest Developments
13.5 Hetero Labs
13.5.1 Hetero Labs Company Information
13.5.2 Hetero Labs Oseltamivir Phosphate for Oral Suspension Product Offered
13.5.3 Hetero Labs Oseltamivir Phosphate for Oral Suspension Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Hetero Labs Main Business Overview
13.5.5 Hetero Labs Latest Developments
13.6 Roche
13.6.1 Roche Company Information
13.6.2 Roche Oseltamivir Phosphate for Oral Suspension Product Offered
13.6.3 Roche Oseltamivir Phosphate for Oral Suspension Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Roche Main Business Overview
13.6.5 Roche Latest Developments
13.7 SJZ No.4 Pharma
13.7.1 SJZ No.4 Pharma Company Information
13.7.2 SJZ No.4 Pharma Oseltamivir Phosphate for Oral Suspension Product Offered
13.7.3 SJZ No.4 Pharma Oseltamivir Phosphate for Oral Suspension Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 SJZ No.4 Pharma Main Business Overview
13.7.5 SJZ No.4 Pharma Latest Developments
13.8 KFBIO
13.8.1 KFBIO Company Information
13.8.2 KFBIO Oseltamivir Phosphate for Oral Suspension Product Offered
13.8.3 KFBIO Oseltamivir Phosphate for Oral Suspension Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 KFBIO Main Business Overview
13.8.5 KFBIO Latest Developments
13.9 Qilu Pharmaceutical
13.9.1 Qilu Pharmaceutical Company Information
13.9.2 Qilu Pharmaceutical Oseltamivir Phosphate for Oral Suspension Product Offered
13.9.3 Qilu Pharmaceutical Oseltamivir Phosphate for Oral Suspension Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Qilu Pharmaceutical Main Business Overview
13.9.5 Qilu Pharmaceutical Latest Developments
13.10 Wanhan Pharmaceutical
13.10.1 Wanhan Pharmaceutical Company Information
13.10.2 Wanhan Pharmaceutical Oseltamivir Phosphate for Oral Suspension Product Offered
13.10.3 Wanhan Pharmaceutical Oseltamivir Phosphate for Oral Suspension Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Wanhan Pharmaceutical Main Business Overview
13.10.5 Wanhan Pharmaceutical Latest Developments
13.11 Nucien
13.11.1 Nucien Company Information
13.11.2 Nucien Oseltamivir Phosphate for Oral Suspension Product Offered
13.11.3 Nucien Oseltamivir Phosphate for Oral Suspension Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Nucien Main Business Overview
13.11.5 Nucien Latest Developments
13.12 Amneal Pharma
13.12.1 Amneal Pharma Company Information
13.12.2 Amneal Pharma Oseltamivir Phosphate for Oral Suspension Product Offered
13.12.3 Amneal Pharma Oseltamivir Phosphate for Oral Suspension Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Amneal Pharma Main Business Overview
13.12.5 Amneal Pharma Latest Developments
13.13 Erye Pharma
13.13.1 Erye Pharma Company Information
13.13.2 Erye Pharma Oseltamivir Phosphate for Oral Suspension Product Offered
13.13.3 Erye Pharma Oseltamivir Phosphate for Oral Suspension Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Erye Pharma Main Business Overview
13.13.5 Erye Pharma Latest Developments
13.14 Alvogen
13.14.1 Alvogen Company Information
13.14.2 Alvogen Oseltamivir Phosphate for Oral Suspension Product Offered
13.14.3 Alvogen Oseltamivir Phosphate for Oral Suspension Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Alvogen Main Business Overview
13.14.5 Alvogen Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Oseltamivir Phosphate for Oral Suspension Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Oseltamivir Phosphate for Oral Suspension Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Aldult
Table 4. Major Players of Child
Table 5. Global Oseltamivir Phosphate for Oral Suspension Sales by Specification (2017-2022) & (K Units)
Table 6. Global Oseltamivir Phosphate for Oral Suspension Sales Market Share by Specification (2017-2022)
Table 7. Global Oseltamivir Phosphate for Oral Suspension Revenue by Specification (2017-2022) & ($ million)
Table 8. Global Oseltamivir Phosphate for Oral Suspension Revenue Market Share by Specification (2017-2022)
Table 9. Global Oseltamivir Phosphate for Oral Suspension Sale Price by Specification (2017-2022) & (US$/Unit)
Table 10. Global Oseltamivir Phosphate for Oral Suspension Sales by Application (2017-2022) & (K Units)
Table 11. Global Oseltamivir Phosphate for Oral Suspension Sales Market Share by Application (2017-2022)
Table 12. Global Oseltamivir Phosphate for Oral Suspension Revenue by Application (2017-2022)
Table 13. Global Oseltamivir Phosphate for Oral Suspension Revenue Market Share by Application (2017-2022)
Table 14. Global Oseltamivir Phosphate for Oral Suspension Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Oseltamivir Phosphate for Oral Suspension Sales by Company (2020-2022) & (K Units)
Table 16. Global Oseltamivir Phosphate for Oral Suspension Sales Market Share by Company (2020-2022)
Table 17. Global Oseltamivir Phosphate for Oral Suspension Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Oseltamivir Phosphate for Oral Suspension Revenue Market Share by Company (2020-2022)
Table 19. Global Oseltamivir Phosphate for Oral Suspension Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Oseltamivir Phosphate for Oral Suspension Producing Area Distribution and Sales Area
Table 21. Players Oseltamivir Phosphate for Oral Suspension Products Offered
Table 22. Oseltamivir Phosphate for Oral Suspension Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Oseltamivir Phosphate for Oral Suspension Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Oseltamivir Phosphate for Oral Suspension Sales Market Share Geographic Region (2017-2022)
Table 27. Global Oseltamivir Phosphate for Oral Suspension Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Oseltamivir Phosphate for Oral Suspension Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Oseltamivir Phosphate for Oral Suspension Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Oseltamivir Phosphate for Oral Suspension Sales Market Share by Country/Region (2017-2022)
Table 31. Global Oseltamivir Phosphate for Oral Suspension Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Oseltamivir Phosphate for Oral Suspension Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Oseltamivir Phosphate for Oral Suspension Sales by Country (2017-2022) & (K Units)
Table 34. Americas Oseltamivir Phosphate for Oral Suspension Sales Market Share by Country (2017-2022)
Table 35. Americas Oseltamivir Phosphate for Oral Suspension Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Oseltamivir Phosphate for Oral Suspension Revenue Market Share by Country (2017-2022)
Table 37. Americas Oseltamivir Phosphate for Oral Suspension Sales by Type (2017-2022) & (K Units)
Table 38. Americas Oseltamivir Phosphate for Oral Suspension Sales Market Share by Specification (2017-2022)
Table 39. Americas Oseltamivir Phosphate for Oral Suspension Sales by Application (2017-2022) & (K Units)
Table 40. Americas Oseltamivir Phosphate for Oral Suspension Sales Market Share by Application (2017-2022)
Table 41. APAC Oseltamivir Phosphate for Oral Suspension Sales by Region (2017-2022) & (K Units)
Table 42. APAC Oseltamivir Phosphate for Oral Suspension Sales Market Share by Region (2017-2022)
Table 43. APAC Oseltamivir Phosphate for Oral Suspension Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Oseltamivir Phosphate for Oral Suspension Revenue Market Share by Region (2017-2022)
Table 45. APAC Oseltamivir Phosphate for Oral Suspension Sales by Specification (2017-2022) & (K Units)
Table 46. APAC Oseltamivir Phosphate for Oral Suspension Sales Market Share by Specification (2017-2022)
Table 47. APAC Oseltamivir Phosphate for Oral Suspension Sales by Application (2017-2022) & (K Units)
Table 48. APAC Oseltamivir Phosphate for Oral Suspension Sales Market Share by Application (2017-2022)
Table 49. Europe Oseltamivir Phosphate for Oral Suspension Sales by Country (2017-2022) & (K Units)
Table 50. Europe Oseltamivir Phosphate for Oral Suspension Sales Market Share by Country (2017-2022)
Table 51. Europe Oseltamivir Phosphate for Oral Suspension Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Oseltamivir Phosphate for Oral Suspension Revenue Market Share by Country (2017-2022)
Table 53. Europe Oseltamivir Phosphate for Oral Suspension Sales by Type (2017-2022) & (K Units)
Table 54. Europe Oseltamivir Phosphate for Oral Suspension Sales Market Share by Specification (2017-2022)
Table 55. Europe Oseltamivir Phosphate for Oral Suspension Sales by Application (2017-2022) & (K Units)
Table 56. Europe Oseltamivir Phosphate for Oral Suspension Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Oseltamivir Phosphate for Oral Suspension Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Oseltamivir Phosphate for Oral Suspension Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Oseltamivir Phosphate for Oral Suspension Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Oseltamivir Phosphate for Oral Suspension Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Oseltamivir Phosphate for Oral Suspension Sales by Specification (2017-2022) & (K Units)
Table 62. Middle East & Africa Oseltamivir Phosphate for Oral Suspension Sales Market Share by Specification (2017-2022)
Table 63. Middle East & Africa Oseltamivir Phosphate for Oral Suspension Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Oseltamivir Phosphate for Oral Suspension Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Oseltamivir Phosphate for Oral Suspension
Table 66. Key Market Challenges & Risks of Oseltamivir Phosphate for Oral Suspension
Table 67. Key Industry Trends of Oseltamivir Phosphate for Oral Suspension
Table 68. Oseltamivir Phosphate for Oral Suspension Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Oseltamivir Phosphate for Oral Suspension Distributors List
Table 71. Oseltamivir Phosphate for Oral Suspension Customer List
Table 72. Global Oseltamivir Phosphate for Oral Suspension Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Oseltamivir Phosphate for Oral Suspension Sales Market Forecast by Region
Table 74. Global Oseltamivir Phosphate for Oral Suspension Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Oseltamivir Phosphate for Oral Suspension Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Oseltamivir Phosphate for Oral Suspension Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Oseltamivir Phosphate for Oral Suspension Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Oseltamivir Phosphate for Oral Suspension Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Oseltamivir Phosphate for Oral Suspension Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Oseltamivir Phosphate for Oral Suspension Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Oseltamivir Phosphate for Oral Suspension Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Oseltamivir Phosphate for Oral Suspension Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Oseltamivir Phosphate for Oral Suspension Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Oseltamivir Phosphate for Oral Suspension Sales Forecast by Specification (2023-2028) & (K Units)
Table 85. Global Oseltamivir Phosphate for Oral Suspension Sales Market Share Forecast by Specification (2023-2028)
Table 86. Global Oseltamivir Phosphate for Oral Suspension Revenue Forecast by Specification (2023-2028) & ($ Millions)
Table 87. Global Oseltamivir Phosphate for Oral Suspension Revenue Market Share Forecast by Specification (2023-2028)
Table 88. Global Oseltamivir Phosphate for Oral Suspension Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Oseltamivir Phosphate for Oral Suspension Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Oseltamivir Phosphate for Oral Suspension Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Oseltamivir Phosphate for Oral Suspension Revenue Market Share Forecast by Application (2023-2028)
Table 92. HEC Basic Information, Oseltamivir Phosphate for Oral Suspension Manufacturing Base, Sales Area and Its Competitors
Table 93. HEC Oseltamivir Phosphate for Oral Suspension Product Offered
Table 94. HEC Oseltamivir Phosphate for Oral Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. HEC Main Business
Table 96. HEC Latest Developments
Table 97. Bright Gene Basic Information, Oseltamivir Phosphate for Oral Suspension Manufacturing Base, Sales Area and Its Competitors
Table 98. Bright Gene Oseltamivir Phosphate for Oral Suspension Product Offered
Table 99. Bright Gene Oseltamivir Phosphate for Oral Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Bright Gene Main Business
Table 101. Bright Gene Latest Developments
Table 102. Brilliant Pharma Basic Information, Oseltamivir Phosphate for Oral Suspension Manufacturing Base, Sales Area and Its Competitors
Table 103. Brilliant Pharma Oseltamivir Phosphate for Oral Suspension Product Offered
Table 104. Brilliant Pharma Oseltamivir Phosphate for Oral Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Brilliant Pharma Main Business
Table 106. Brilliant Pharma Latest Developments
Table 107. Kanon Basic Information, Oseltamivir Phosphate for Oral Suspension Manufacturing Base, Sales Area and Its Competitors
Table 108. Kanon Oseltamivir Phosphate for Oral Suspension Product Offered
Table 109. Kanon Oseltamivir Phosphate for Oral Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Kanon Main Business
Table 111. Kanon Latest Developments
Table 112. Hetero Labs Basic Information, Oseltamivir Phosphate for Oral Suspension Manufacturing Base, Sales Area and Its Competitors
Table 113. Hetero Labs Oseltamivir Phosphate for Oral Suspension Product Offered
Table 114. Hetero Labs Oseltamivir Phosphate for Oral Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Hetero Labs Main Business
Table 116. Hetero Labs Latest Developments
Table 117. Roche Basic Information, Oseltamivir Phosphate for Oral Suspension Manufacturing Base, Sales Area and Its Competitors
Table 118. Roche Oseltamivir Phosphate for Oral Suspension Product Offered
Table 119. Roche Oseltamivir Phosphate for Oral Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Roche Main Business
Table 121. Roche Latest Developments
Table 122. SJZ No.4 Pharma Basic Information, Oseltamivir Phosphate for Oral Suspension Manufacturing Base, Sales Area and Its Competitors
Table 123. SJZ No.4 Pharma Oseltamivir Phosphate for Oral Suspension Product Offered
Table 124. SJZ No.4 Pharma Oseltamivir Phosphate for Oral Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. SJZ No.4 Pharma Main Business
Table 126. SJZ No.4 Pharma Latest Developments
Table 127. KFBIO Basic Information, Oseltamivir Phosphate for Oral Suspension Manufacturing Base, Sales Area and Its Competitors
Table 128. KFBIO Oseltamivir Phosphate for Oral Suspension Product Offered
Table 129. KFBIO Oseltamivir Phosphate for Oral Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. KFBIO Main Business
Table 131. KFBIO Latest Developments
Table 132. Qilu Pharmaceutical Basic Information, Oseltamivir Phosphate for Oral Suspension Manufacturing Base, Sales Area and Its Competitors
Table 133. Qilu Pharmaceutical Oseltamivir Phosphate for Oral Suspension Product Offered
Table 134. Qilu Pharmaceutical Oseltamivir Phosphate for Oral Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Qilu Pharmaceutical Main Business
Table 136. Qilu Pharmaceutical Latest Developments
Table 137. Wanhan Pharmaceutical Basic Information, Oseltamivir Phosphate for Oral Suspension Manufacturing Base, Sales Area and Its Competitors
Table 138. Wanhan Pharmaceutical Oseltamivir Phosphate for Oral Suspension Product Offered
Table 139. Wanhan Pharmaceutical Oseltamivir Phosphate for Oral Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Wanhan Pharmaceutical Main Business
Table 141. Wanhan Pharmaceutical Latest Developments
Table 142. Nucien Basic Information, Oseltamivir Phosphate for Oral Suspension Manufacturing Base, Sales Area and Its Competitors
Table 143. Nucien Oseltamivir Phosphate for Oral Suspension Product Offered
Table 144. Nucien Oseltamivir Phosphate for Oral Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Nucien Main Business
Table 146. Nucien Latest Developments
Table 147. Amneal Pharma Basic Information, Oseltamivir Phosphate for Oral Suspension Manufacturing Base, Sales Area and Its Competitors
Table 148. Amneal Pharma Oseltamivir Phosphate for Oral Suspension Product Offered
Table 149. Amneal Pharma Oseltamivir Phosphate for Oral Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Amneal Pharma Main Business
Table 151. Amneal Pharma Latest Developments
Table 152. Erye Pharma Basic Information, Oseltamivir Phosphate for Oral Suspension Manufacturing Base, Sales Area and Its Competitors
Table 153. Erye Pharma Oseltamivir Phosphate for Oral Suspension Product Offered
Table 154. Erye Pharma Oseltamivir Phosphate for Oral Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Erye Pharma Main Business
Table 156. Erye Pharma Latest Developments
Table 157. Alvogen Basic Information, Oseltamivir Phosphate for Oral Suspension Manufacturing Base, Sales Area and Its Competitors
Table 158. Alvogen Oseltamivir Phosphate for Oral Suspension Product Offered
Table 159. Alvogen Oseltamivir Phosphate for Oral Suspension Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Alvogen Main Business
Table 161. Alvogen Latest Developments
List of Figures
Figure 1. Picture of Oseltamivir Phosphate for Oral Suspension
Figure 2. Oseltamivir Phosphate for Oral Suspension Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oseltamivir Phosphate for Oral Suspension Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Oseltamivir Phosphate for Oral Suspension Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Oseltamivir Phosphate for Oral Suspension Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Aldult
Figure 10. Product Picture of Child
Figure 11. Global Oseltamivir Phosphate for Oral Suspension Sales Market Share by Specification in 2021
Figure 12. Global Oseltamivir Phosphate for Oral Suspension Revenue Market Share by Specification (2017-2022)
Figure 13. Oseltamivir Phosphate for Oral Suspension Consumed in Hospital
Figure 14. Global Oseltamivir Phosphate for Oral Suspension Market: Hospital (2017-2022) & (K Units)
Figure 15. Oseltamivir Phosphate for Oral Suspension Consumed in Clinic
Figure 16. Global Oseltamivir Phosphate for Oral Suspension Market: Clinic (2017-2022) & (K Units)
Figure 17. Oseltamivir Phosphate for Oral Suspension Consumed in Other
Figure 18. Global Oseltamivir Phosphate for Oral Suspension Market: Other (2017-2022) & (K Units)
Figure 19. Global Oseltamivir Phosphate for Oral Suspension Sales Market Share by Application (2017-2022)
Figure 20. Global Oseltamivir Phosphate for Oral Suspension Revenue Market Share by Application in 2021
Figure 21. Oseltamivir Phosphate for Oral Suspension Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Oseltamivir Phosphate for Oral Suspension Revenue Market Share by Company in 2021
Figure 23. Global Oseltamivir Phosphate for Oral Suspension Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Oseltamivir Phosphate for Oral Suspension Revenue Market Share by Geographic Region in 2021
Figure 25. Global Oseltamivir Phosphate for Oral Suspension Sales Market Share by Region (2017-2022)
Figure 26. Global Oseltamivir Phosphate for Oral Suspension Revenue Market Share by Country/Region in 2021
Figure 27. Americas Oseltamivir Phosphate for Oral Suspension Sales 2017-2022 (K Units)
Figure 28. Americas Oseltamivir Phosphate for Oral Suspension Revenue 2017-2022 ($ Millions)
Figure 29. APAC Oseltamivir Phosphate for Oral Suspension Sales 2017-2022 (K Units)
Figure 30. APAC Oseltamivir Phosphate for Oral Suspension Revenue 2017-2022 ($ Millions)
Figure 31. Europe Oseltamivir Phosphate for Oral Suspension Sales 2017-2022 (K Units)
Figure 32. Europe Oseltamivir Phosphate for Oral Suspension Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Oseltamivir Phosphate for Oral Suspension Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Oseltamivir Phosphate for Oral Suspension Revenue 2017-2022 ($ Millions)
Figure 35. Americas Oseltamivir Phosphate for Oral Suspension Sales Market Share by Country in 2021
Figure 36. Americas Oseltamivir Phosphate for Oral Suspension Revenue Market Share by Country in 2021
Figure 37. United States Oseltamivir Phosphate for Oral Suspension Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Oseltamivir Phosphate for Oral Suspension Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Oseltamivir Phosphate for Oral Suspension Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Oseltamivir Phosphate for Oral Suspension Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Oseltamivir Phosphate for Oral Suspension Sales Market Share by Region in 2021
Figure 42. APAC Oseltamivir Phosphate for Oral Suspension Revenue Market Share by Regions in 2021
Figure 43. China Oseltamivir Phosphate for Oral Suspension Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Oseltamivir Phosphate for Oral Suspension Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Oseltamivir Phosphate for Oral Suspension Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Oseltamivir Phosphate for Oral Suspension Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Oseltamivir Phosphate for Oral Suspension Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Oseltamivir Phosphate for Oral Suspension Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Oseltamivir Phosphate for Oral Suspension Sales Market Share by Country in 2021
Figure 50. Europe Oseltamivir Phosphate for Oral Suspension Revenue Market Share by Country in 2021
Figure 51. Germany Oseltamivir Phosphate for Oral Suspension Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Oseltamivir Phosphate for Oral Suspension Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Oseltamivir Phosphate for Oral Suspension Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Oseltamivir Phosphate for Oral Suspension Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Oseltamivir Phosphate for Oral Suspension Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Oseltamivir Phosphate for Oral Suspension Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Oseltamivir Phosphate for Oral Suspension Revenue Market Share by Country in 2021
Figure 58. Egypt Oseltamivir Phosphate for Oral Suspension Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Oseltamivir Phosphate for Oral Suspension Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Oseltamivir Phosphate for Oral Suspension Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Oseltamivir Phosphate for Oral Suspension Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Oseltamivir Phosphate for Oral Suspension Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Oseltamivir Phosphate for Oral Suspension in 2021
Figure 64. Manufacturing Process Analysis of Oseltamivir Phosphate for Oral Suspension
Figure 65. Industry Chain Structure of Oseltamivir Phosphate for Oral Suspension
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets